Capital World Investors Alnylam Pharmaceuticals, Inc. Transaction History
Capital World Investors
- $659 Billion
- Q2 2025
A detailed history of Capital World Investors transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital World Investors holds 16,805,007 shares of ALNY stock, worth $7.22 Billion. This represents 0.83% of its overall portfolio holdings.
Number of Shares
16,805,007
Previous 16,749,623
0.33%
Holding current value
$7.22 Billion
Previous $4.52 Billion
21.16%
% of portfolio
0.83%
Previous 0.76%
Shares
17 transactions
Others Institutions Holding ALNY
# of Institutions
742Shares Held
115MCall Options Held
588KPut Options Held
669K-
Vanguard Group Inc Valley Forge, PA13.3MShares$5.72 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.1 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.09 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.28MShares$1.84 Billion0.88% of portfolio
-
Dodge & Cox San Francisco, CA3.2MShares$1.37 Billion0.63% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $52.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...